Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp study

By Tornøe Christoffer Wenzel   Jacobsen Judith L.   Madsen Henrik  

Journal of Mathematical Biology, Vol. 48, Iss. 6, 2004-06 ,pp. : 591-604

Springer Publishing Company

Access to resources Recommend Favorite

A novel role of transient receptor potential mucolipin1 (TRPML1) in protecting against imidazole-induced cytotoxicity

By Liu Zhenxing   Zhao Shuan   Wu Shuaishuai   Zhang Jingyou   Nie Zunyang   Zeng Shenming  

Biochemistry and Cell Biology, Vol. 92, Iss. 4, 2014-01 ,pp. : 279-286

NRC Research Press

Access to resources Recommend Favorite

Enzymatic Measurement of Sphingosine 1-Phosphate

By Edsall L.C.   Spiegel S.  

Analytical Biochemistry, Vol. 272, Iss. 1, 1999-07 ,pp. : 80-86

Elsevier

Access to resources Recommend Favorite

Preclinical assessment of novel BRAF inhibitors: integrating pharmacokinetic-pharmacodynamic modelling in the drug discovery process

By Choo Edna F   Alicke Bruno   Boggs Jason   Dinkel Vikki   Gould Stephen   Grina Jonas   West Kristina   Menghrajani Kapil   Ran Yingqing   Rudolph Joachim   Wenglowsky Steve  

Xenobiotica, Vol. 41, Iss. 12, 2011-12 ,pp. : 1076-1087

Informa Healthcare

Access to resources Recommend Favorite

The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P₁ agonists

By Taylor Simon   Gray James R. J.   Willis Robert   Deeks Nigel   Haynes Andrea   Campbell Colin   Gaskin Pam   Leavens Karen   Demont Emmanuel   Dowell Simon   Cryan Jenni   Morse Mary   Patel Aarti   Garden Helen   Witherington Jason  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 671-686

Informa Healthcare

Access to resources Recommend Favorite